Patent directory · USPTO A61K / A61P
Patents matching “Takeda Pharmaceutical Company Limited”
1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11285139
Treatment of CNS conditions
granted -
US 11279713
Heterocyclic compound and use thereof
granted -
US 11274101
Heterocyclic compound
granted -
US 11273182
Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease
granted -
US 11268154
Methods for the identification, evaluation and treatment of patients having multiple myeloma
granted -
US 11254731
Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A
granted -
US 11242380
Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
granted -
US 11236099
Heterocyclic compound
granted -
US 11230541
Heterocyclic compound
granted -
US 11230545
Heterocyclic compound
granted -
US 11202776
Treatment of gastroparesis with triazaspiro[4.5]decanone
granted -
US 11197916
Lyophilized recombinant VWF formulations
granted -
US 11191837
Recombinant VWF formulations
granted -
US 11191813
Lyophilized recombinant VWF formulations
granted -
US 11191818
Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome
granted -
US 11185575
Subcutaneous administration of ADAMTS13
granted -
US 11186565
Aromatic compound
granted -
US 11173161
4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139
granted -
US 11174272
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
granted -
US 11174301
Peptide compound
granted -
US 11173147
Prophylactic or therapeutic agent for delirium
granted -
US 11168083
Inhibitors of Plasma Kallikrein and uses thereof
granted -
US 11160850
Compositions of human prothrombin and activated factor X for improving hemostasis in the treatment of bleeding disorders
granted -
US 11156612
Methods of determining levels of cleaved and/or intact kininogen
granted